For: | Alam S, Fahim SM. Transition of an acronym from nonalcoholic fatty liver disease to metabolic dysfunction-associated fatty liver disease. World J Hepatol 2021; 13(10): 1203-1207 [PMID: PMC8568582 DOI: 10.4254/wjh.v13.i10.1203] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v13/i10/1203.htm |
Number | Citing Articles |
1 |
Magdi A. Ali, Eman El-Abd, Mohamed Morsi, Mohamed M. El Safwany, Mohamed Z. El-Sayed. The effect of hepatic steatosis on 18F-FDG uptake in PET-CT examinations of cancer Egyptian patients. European Journal of Hybrid Imaging 2023; 7(1) doi: 10.1186/s41824-023-00173-6
|
2 |
Cui Zhang, Lili Cao, Bo Xu, Wei Zhang. Interaction between trouble sleeping and diabetes on metabolic dysfunction-associated fatty liver disease and liver fibrosis in adults results from the National Health and Nutrition Examination Survey 2017–2018. European Journal of Gastroenterology & Hepatology 2024; 36(12): 1437 doi: 10.1097/MEG.0000000000002860
|
3 |
Mohamed M. Elseweidy, Ahmed E. Elesawy, Mohammed S. Sobh, Gehad M. Elnagar. Ellagic acid ameliorates high fructose-induced hyperuricemia and non-alcoholic fatty liver in Wistar rats: Focusing on the role of C1q/tumor necrosis factor-related protein-3 and ATP citrate lyase. Life Sciences 2022; 305: 120751 doi: 10.1016/j.lfs.2022.120751
|